Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04794387 · ClinicalTrials.gov registry record
The Lymphoma and Leukemia Society Amended COVID-19 Registry
A clinical trial, sponsored by Blood Cancer United.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT04794387 is a clinical trial that has completed, run by Blood Cancer United. The registered enrollment target is 1,000 participants.
The verdict
NCT04794387 has completed, sponsored by Blood Cancer United.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The LLS COVID-19 Registry is being amended to invite people who participated in the LLS COVID-19 Registry and did not develop antibodies after receiving a complete COVID-19 vaccination, as well as people with blood cancer who did not participate in the initial LLS COVID-19 Registry and also did not develop antibodies after receiving a complete COVID-19 vaccination, to participate in this amended LLS COVID-19 Registry.
Interventions
- BIOLOGICAL Amended LLS COVID-19 Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2022-12-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04794387
The ClinicalTrials.gov registry entry for NCT04794387 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Blood Cancer United, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Amended LLS COVID-19 Registry is the first listed.
NCT04794387 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04794387 about?
NCT04794387 is a clinical study titled "The Lymphoma and Leukemia Society Amended COVID-19 Registry". The LLS COVID-19 Registry is being amended to invite people who participated in the LLS COVID-19 Registry and did not develop antibodies after receiving a complete COVID-19 vaccination, as well as people with blood cancer who did not participate in the initial LLS COVID-19 Registry and also did not ...
What is the current status of trial NCT04794387?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2021-08-27. Estimated completion is 2022-12-13.
What interventions are being tested in trial NCT04794387?
The interventions under investigation include: Amended LLS COVID-19 Registry (BIOLOGICAL).
Who is sponsoring clinical trial NCT04794387?
This trial is sponsored by Blood Cancer United, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.